Zhongzhi Pharma Expects 40% Profit Drop

Zhongzhi Pharmaceutical Holdings Limited (HK:3737) has released an update.

Zhongzhi Pharmaceutical Holdings Limited has issued a profit warning, anticipating a 40% decrease in net profit for the first half of 2024 compared to the previous year. The decline is primarily attributed to lower gross profit margins due to product mix changes and heightened investment in online channels. Investors are urged to exercise caution when dealing with the company’s shares and to await the official interim results announcement expected before the end of August 2024.

For further insights into HK:3737 stock, check out TipRanks’ Stock Analysis page.